Picture of Lumibird SA logo

LBIRD — Lumibird SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Lumibird Q4 Revenue Down At 33.6 Million Euros

Jan 28 (Reuters) - Lumibird SA  LBIRD.PA :
    * REPORTED ON MONDAY 2019 FULL-YEAR REVENUES AND REVISION OF
THE
2021 REVENUE TARGET
    * Q4 REVENUE EUR 33.6 MLN VS EUR 35.2 MLN YEAR AGO
    * TREND FOR ORGANIC GROWTH IS CONTINUING IN 2020 AND IS
EXPECTED
TO BE FURTHER STRENGTHENED WITH ELLEX’S ACTIVITIES FOR MEDICAL
BRANCH FOR AROUND EUR 40 MLN PRO FORMA
    * TURNOVER TARGET OF EUR 150 MLN PER ORGANIC GROWTH IN 2021
IS
POSTPONED TO 2022
    * MAINTAINS TARGET OF 20% EBITDA MARGIN FOR 2021

Source text for Eikon:  ID:nBw9XttWwa 
Further company coverage:  LBIRD.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Lumibird SA

See all news